{"id":"human-plasminogen","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Hemorrhage"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Human plasminogen is a protein that plays a key role in the fibrinolytic system, which is responsible for breaking down blood clots. By activating plasminogen, this drug helps to dissolve blood clots and restore normal blood flow.","oneSentence":"Activates plasminogen to break down blood clots","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:00:52.067Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke"},{"name":"Pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT07471256","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Intracerebral Hemorrhage Lobar","enrollment":636},{"nctId":"NCT07466524","phase":"","title":"suPAR Michigan M2C2 Heterogeneity Validation Cohort Study","status":"COMPLETED","sponsor":"ViroGates A/S","startDate":"2020-02-01","conditions":"COVID-19, Severe Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome","enrollment":367},{"nctId":"NCT07253181","phase":"PHASE3","title":"Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-06","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients","enrollment":572},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07361302","phase":"PHASE3","title":"A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-02-17","conditions":"Acute Ischemic Stroke","enrollment":1325},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT07471282","phase":"PHASE3","title":"Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Chuansheng Zhao","startDate":"2026-03-01","conditions":"Stroke","enrollment":344},{"nctId":"NCT05491356","phase":"PHASE4","title":"Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2023-05-11","conditions":"Hematoma, Subdural, Fibrinolytic; Hemorrhage","enrollment":40},{"nctId":"NCT07432373","phase":"","title":"Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection","status":"NOT_YET_RECRUITING","sponsor":"National University of Malaysia","startDate":"2026-04-01","conditions":"Pleural Infection","enrollment":80},{"nctId":"NCT05903417","phase":"NA","title":"Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2023-07-10","conditions":"Pleural Infection","enrollment":40},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT05983757","phase":"NA","title":"Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe","status":"RECRUITING","sponsor":"Raul Nogueira","startDate":"2024-04-02","conditions":"Ischemic Stroke","enrollment":584},{"nctId":"NCT06427538","phase":"NA","title":"Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-06-21","conditions":"Empyema, Pleural, Pleural Infection","enrollment":96},{"nctId":"NCT07375953","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":120},{"nctId":"NCT07375966","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":198},{"nctId":"NCT05701956","phase":"PHASE3","title":"Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-03-16","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":330},{"nctId":"NCT07411079","phase":"","title":"Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Intracerebral Hemorrhage, Hemorrhagic Risk Conditions, Bleeding Disorders","enrollment":1126},{"nctId":"NCT05499832","phase":"PHASE3","title":"Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-03-21","conditions":"Ischemic Stroke","enrollment":156},{"nctId":"NCT02557451","phase":"NA","title":"Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2016-04-28","conditions":"Subretinal Haematoma Linked to AMD","enrollment":91},{"nctId":"NCT06659640","phase":"PHASE1, PHASE2","title":"A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","status":"RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2024-11-07","conditions":"Hereditary Hemorrhagic Telangiectasia","enrollment":120},{"nctId":"NCT04663750","phase":"PHASE3","title":"Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2021-04-16","conditions":"Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage","enrollment":210},{"nctId":"NCT05953480","phase":"PHASE2","title":"A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shionogi","startDate":"2023-07-14","conditions":"Acute Ischemic Stroke","enrollment":680},{"nctId":"NCT07111559","phase":"PHASE4","title":"Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial","status":"RECRUITING","sponsor":"Nippon Medical School","startDate":"2025-08-01","conditions":"Lacunar Stroke, Stroke, Ischemic Stroke","enrollment":500},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06797999","phase":"PHASE1, PHASE2","title":"First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Adcendo ApS","startDate":"2025-06-05","conditions":"Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma","enrollment":270},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT07360717","phase":"NA","title":"To Compare the Efficacy & Safety of Ultra-Slow (24 hr) Low Dose (25 mg) Infusion of Alteplase Over Slow (24hr) Infusion of Streptokinase in Mechanical Prosthetic Valve Thrombosis","status":"COMPLETED","sponsor":"U. N. Mehta Institute of Cardiology and Research Center","startDate":"2024-11-01","conditions":"Thrombolysed","enrollment":100},{"nctId":"NCT06658197","phase":"PHASE3","title":"Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-25","conditions":"Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain","enrollment":850},{"nctId":"NCT06310018","phase":"","title":"Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE","status":"SUSPENDED","sponsor":"Brigham and Women's Hospital","startDate":"2027-01-01","conditions":"Pulmonary Embolism, Right Ventricular Dysfunction, Right Ventricular Failure","enrollment":60},{"nctId":"NCT07302854","phase":"PHASE2, PHASE3","title":"Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2025-12-30","conditions":"Acute Ischemic Stroke, Medium Vessel Occlusion","enrollment":382},{"nctId":"NCT07003646","phase":"","title":"Reperfusion Treatment in Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2025-04-01","conditions":"Pulmonary Embolism","enrollment":220},{"nctId":"NCT06949228","phase":"PHASE2, PHASE3","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","status":"RECRUITING","sponsor":"ProMedica Health System","startDate":"2025-07-30","conditions":"Ischemic Stroke, Acute Disease","enrollment":132},{"nctId":"NCT02125617","phase":"","title":"Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer","status":"TERMINATED","sponsor":"Kristoffer Rohrberg","startDate":"2014-01","conditions":"Prostatic Neoplasms","enrollment":3},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT00412867","phase":"PHASE4","title":"Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2006-12","conditions":"Stroke","enrollment":58},{"nctId":"NCT05766124","phase":"PHASE2, PHASE3","title":"Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-11-01","conditions":"Pleural Infection","enrollment":30},{"nctId":"NCT00147316","phase":"PHASE3","title":"Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2002-04","conditions":"Cerebral Infarction, Brain Ischemia","enrollment":103},{"nctId":"NCT05728333","phase":"PHASE2, PHASE3","title":"Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2023-11-28","conditions":"Stroke, Acute Ischemic","enrollment":800},{"nctId":"NCT06184321","phase":"EARLY_PHASE1","title":"Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-08-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":30},{"nctId":"NCT07092709","phase":"PHASE3","title":"Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-14","conditions":"Acute Ischemic Stroke","enrollment":912},{"nctId":"NCT07201688","phase":"PHASE3","title":"Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.","status":"RECRUITING","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-30","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT05752916","phase":"PHASE4","title":"Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-06-02","conditions":"Acute Ischemic Stroke","enrollment":570},{"nctId":"NCT07208097","phase":"NA","title":"Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-10-25","conditions":"Intracerebral Haemorrhage, Minimally Invasive Treatment","enrollment":768},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT06196320","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-24","conditions":"Ischemic Stroke, Acute","enrollment":452},{"nctId":"NCT05631847","phase":"NA","title":"Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke","status":"COMPLETED","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2023-04-17","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis","enrollment":345},{"nctId":"NCT07227740","phase":"","title":"Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury","status":"RECRUITING","sponsor":"Craig Hospital","startDate":"2025-07-15","conditions":"Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency","enrollment":48},{"nctId":"NCT07047014","phase":"PHASE3","title":"Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-30","conditions":"Stroke, Ischemic, Medium Vessel Occlusions","enrollment":596},{"nctId":"NCT06954155","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-30","conditions":"Stroke","enrollment":330},{"nctId":"NCT04526951","phase":"PHASE3","title":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-10-30","conditions":"Central Retinal Artery Occlusion","enrollment":81},{"nctId":"NCT03335839","phase":"PHASE3","title":"Adjunctive, Low-dose tPA in Primary PCI for STEMI","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-04-01","conditions":"Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":210},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT05797792","phase":"PHASE3","title":"CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-11-18","conditions":"Stroke, Acute Ischemic, Stroke, Acute","enrollment":440},{"nctId":"NCT03424460","phase":"NA","title":"Venous Thromboembolism in Myotonic Dystrophy Type 1","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-06-11","conditions":"Myotonic Dystrophy 1","enrollment":130},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794},{"nctId":"NCT06868797","phase":"NA","title":"Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-08-29","conditions":"Heart Failure","enrollment":103},{"nctId":"NCT07095361","phase":"PHASE4","title":"Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-09","conditions":"Pleural Infection Bacterial, Pleural Infections, Pleural Infections and Inflammations","enrollment":270},{"nctId":"NCT06337175","phase":"PHASE4","title":"Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2021-06-01","conditions":"Ischemic Stroke, Alteplase Adverse Reaction","enrollment":600},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT06010628","phase":"PHASE4","title":"Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-02-01","conditions":"Stroke, Ischemic","enrollment":1440},{"nctId":"NCT02315898","phase":"PHASE2","title":"Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2018-03-19","conditions":"Plastic Bronchitis, Protein-Losing Enteropathies, Healthy","enrollment":40},{"nctId":"NCT07073469","phase":"PHASE3","title":"Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Stroke Ischemic","enrollment":330},{"nctId":"NCT05897554","phase":"NA","title":"Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-08-11","conditions":"Acute Ischemic Stroke, Arterial Thrombosis, Posterior Circulation Brain Infarction","enrollment":247},{"nctId":"NCT06001645","phase":"","title":"Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)","status":"RECRUITING","sponsor":"Università Vita-Salute San Raffaele","startDate":"2023-11-27","conditions":"Acute Respiratory Distress Syndrome, Barotrauma","enrollment":110},{"nctId":"NCT04356833","phase":"PHASE2","title":"Nebulised Rt-PA for ARDS Due to COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-04-22","conditions":"COVID","enrollment":35},{"nctId":"NCT07098676","phase":"","title":"Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Ai Peng","startDate":"2024-11-20","conditions":"Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients","enrollment":900},{"nctId":"NCT03187405","phase":"PHASE3","title":"Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage.","status":"TERMINATED","sponsor":"University Hospital, Caen","startDate":"2018-02-21","conditions":"Subarachnoid Hemorrhage","enrollment":81},{"nctId":"NCT06367166","phase":"NA","title":"Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ryazan State Medical University","startDate":"2023-04-01","conditions":"Varicose Veins of Lower Limb, Varix, Vascular Diseases","enrollment":100},{"nctId":"NCT05657457","phase":"PHASE3","title":"Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT)","status":"TERMINATED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":145},{"nctId":"NCT05583305","phase":"","title":"Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-12","conditions":"Antiphospholipid Syndrome, Stenosis, Intracranial Stenosis","enrollment":60},{"nctId":"NCT05657470","phase":"PHASE2, PHASE3","title":"Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":80},{"nctId":"NCT05542277","phase":"NA","title":"A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement","status":"TERMINATED","sponsor":"PlasFree Ltd.","startDate":"2022-11-08","conditions":"Bleeding, Bypass Complication, Valve Replacement","enrollment":130},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT06801054","phase":"PHASE1","title":"Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose","status":"NOT_YET_RECRUITING","sponsor":"Memorial Hermann Health System","startDate":"2025-07-01","conditions":"Acute Ischemic Stroke","enrollment":20},{"nctId":"NCT06713382","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-04-10","conditions":"Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, Pleural Effusions","enrollment":96},{"nctId":"NCT06980519","phase":"","title":"MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer","status":"AVAILABLE","sponsor":"Monopar Therapeutics","startDate":"","conditions":"Cancer, Solid Tumor, Solid Tumor Cancer","enrollment":""},{"nctId":"NCT06980506","phase":"","title":"MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer","status":"AVAILABLE","sponsor":"Monopar Therapeutics","startDate":"","conditions":"Cancer, Solid Tumor, Solid Tumor, Adult","enrollment":""},{"nctId":"NCT06187987","phase":"","title":"Mechanical Thrombectomy With the FlowTriever Device in Acute Pulmonary Embolism - a Retrospective Analysis","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2023-04-01","conditions":"Pulmonary Embolism","enrollment":132},{"nctId":"NCT04430569","phase":"PHASE3","title":"Pulmonary Embolism International THrOmbolysis Study-3","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-08-04","conditions":"Pulmonary Embolism","enrollment":800},{"nctId":"NCT06769256","phase":"PHASE4","title":"Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2025-01-01","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":300},{"nctId":"NCT06961435","phase":"","title":"An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2019-01-01","conditions":"Colitis, Ulcerative","enrollment":900},{"nctId":"NCT04965038","phase":"PHASE3","title":"Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2022-10-10","conditions":"Central Retinal Artery Occlusion","enrollment":422},{"nctId":"NCT06868511","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-25","conditions":"Deep Intracerebral Hemorrhage (ICH)","enrollment":732},{"nctId":"NCT06935942","phase":"","title":"The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2020-01-01","conditions":"Crohn Disease","enrollment":906},{"nctId":"NCT05199194","phase":"PHASE3","title":"Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-05-27","conditions":"Stroke, Ischemic, Stroke, Acute","enrollment":398},{"nctId":"NCT05199662","phase":"PHASE3","title":"Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-01-20","conditions":"Ischemic Stroke, Acute","enrollment":466},{"nctId":"NCT04733742","phase":"PHASE2, PHASE3","title":"Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke","status":"COMPLETED","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2022-05-09","conditions":"Stroke, Acute, Stroke, Ischemic","enrollment":550},{"nctId":"NCT03151993","phase":"PHASE3","title":"Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2017-03-18","conditions":"Ischemic Stroke","enrollment":336},{"nctId":"NCT04688320","phase":"PHASE3","title":"Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2020-12-15","conditions":"Massive Pulmonary Embolism","enrollment":310},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT05657444","phase":"PHASE3","title":"Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":380},{"nctId":"NCT02301910","phase":"PHASE3","title":"Single Bolus Recombinant Nonimmunogenic Staphylokinase Versus Single Bolus Tenecteplase (Metalyse) in STEMI","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2014-05-16","conditions":"Myocardial Infarction","enrollment":382},{"nctId":"NCT05899465","phase":"PHASE3","title":"Perioperative Treatment With Tranexamic Acid in Melanoma","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-08-25","conditions":"Melanoma","enrollment":1204},{"nctId":"NCT05635786","phase":"","title":"Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-01-02","conditions":"Acute Distal Vessel Occlusion Stroke","enrollment":319},{"nctId":"NCT06660719","phase":"PHASE3","title":"Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care","status":"RECRUITING","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2025-02-14","conditions":"Ischemic Stroke","enrollment":852},{"nctId":"NCT06668441","phase":"PHASE1","title":"Minimally Invasive Surgery and RhTNK-tPA for Intracerebral Hemorrhage Evacuation","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-11-04","conditions":"Intracranial Hemorrhages, Cerebrovascular Disorders, Cerebral Hemorrhage","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1019,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Human Plasminogen","genericName":"Human Plasminogen","companyName":"Kedrion S.p.A.","companyId":"kedrion-s-p-a","modality":"Biologic","firstApprovalDate":"","aiSummary":"Activates plasminogen to break down blood clots Used for Acute ischemic stroke, Pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}